The contribution of clinical pharmacology surrogates and models to drug development--a critical appraisal

Br J Clin Pharmacol. 1997 Sep;44(3):219-25. doi: 10.1046/j.1365-2125.1997.t01-1-00583.x.
No abstract available

Publication types

  • Review

MeSH terms

  • Biomarkers*
  • Clinical Trials as Topic / methods*
  • Drug Approval
  • Humans
  • Pharmacology, Clinical*
  • Sensitivity and Specificity

Substances

  • Biomarkers